The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes
出版年份 2013 全文链接
标题
The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes
作者
关键词
-
出版物
DIABETES-METABOLISM RESEARCH AND REVIEWS
Volume 30, Issue 3, Pages 191-200
出版商
Wiley
发表日期
2013-09-11
DOI
10.1002/dmrr.2466
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Type 2 diabetes and bone fractures
- (2013) Kendall F. Moseley Current Opinion in Endocrinology Diabetes and Obesity
- MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice
- (2012) Alpana Bhattacharjee et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes
- (2012) Sho-ichi Yamagishi et al. CURRENT PHARMACEUTICAL DESIGN
- Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
- (2012) H. M. Colhoun et al. DIABETOLOGIA
- Type 2 diabetes and bone
- (2012) William D Leslie et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sitagliptin Exerts an Antinflammatory Action
- (2012) Antoine Makdissi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of gene pathways altered by deletion of the androgen receptor specifically in mineralizing osteoblasts and osteocytes in mice
- (2012) Patricia K Russell et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Bone, sweet bone—osteoporotic fractures in diabetes mellitus
- (2012) Christine Hamann et al. Nature Reviews Endocrinology
- Short-term effects of zoledronate on the histomorphology of osteoclast in young albino rats
- (2011) Sarah Ralte et al. ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
- Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes
- (2011) Sho-ichi Yamagishi CURRENT DRUG TARGETS
- Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
- (2011) M. Monami et al. DIABETES CARE
- Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetes
- (2011) Jun Iwamoto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial
- (2011) Wenying Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia
- (2011) Bernardo Nuche-Berenguer et al. JOURNAL OF ENDOCRINOLOGY
- Serum IGF-1 Affects Skeletal Acquisition in a Temporal and Compartment-Specific Manner
- (2011) Hayden-William Courtland et al. PLoS One
- Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients*
- (2011) Mathijs C. BUNCK et al. Journal of Diabetes
- Are Antiresorptive Drugs Effective Against Fractures in Patients with Diabetes?
- (2010) Peter Vestergaard et al. CALCIFIED TISSUE INTERNATIONAL
- Differential Effects of PPAR-γ ActivationversusChemical or Genetic Reduction of DPP-4 Activity on Bone Quality in Mice
- (2010) Kimberly A. Kyle et al. ENDOCRINOLOGY
- Growth hormone mediates pubertal skeletal development independent of hepatic IGF-1 production
- (2010) Hayden-William Courtland et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor
- (2010) Bernardo Nuche-Berenguer et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet–induced obesity
- (2010) Janina M. Patsch et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Bone Health and Type 2 Diabetes Mellitus: A Systematic Review
- (2010) Erin Gorman et al. Physiotherapy Canada
- Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow
- (2009) C. Sanz et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy
- (2009) Robert S. Weinstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states
- (2009) Bernardo Nuche-Berenguer et al. REGULATORY PEPTIDES
- Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
- (2009) Unni Syversen et al. BMC Endocrine Disorders
- Diabetes and fragility fractures — A burgeoning epidemic?
- (2008) Sol Epstein et al. BONE
- Body mass influences cortical bone mass independent of leptin signaling
- (2008) U.T. Iwaniec et al. BONE
- Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis
- (2008) Yuki Kawashima et al. BONE
- Insulin Regulates Glucagon-Like Peptide-1 Secretion from the Enteroendocrine L Cell
- (2008) Gareth E. Lim et al. ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now